Novel molecular hybrids of cinnamic acids and guanylhydrazones as potential antitubercular agents. 2010

Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
Institute of Chemical Technology, Nathalal Parikh Marg, Matunga, Mumbai 400 019, India.

In an attempt to identify potential new agents active against tuberculosis, 20 novel phenylacrylamide derivatives incorporating cinnamic acids and guanylhydrazones were synthesized using microwave assisted synthesis. Activity of the synthesized compounds was evaluated using resazurin microtitre plate assay (REMA) against Mycobacterium tuberculosis H37Rv. Based on empirical structure-activity relationship data it was observed that both steric and electronic parameters play major role in the activity of this series of compounds. Compound 7s (2E)-N-((-2-(3,4-dimethoxybenzylidene) hydrazinyl) (imino) methyl)-3-(4-methoxyphenyl) acrylamide showed MIC of 6.49microM along with good safety profile of >50-fold in VERO cell line. Thus, this compound could act as a potential lead for further antitubercular studies.

UI MeSH Term Description Entries
D008872 Microwaves That portion of the electromagnetic spectrum from the UHF (ultrahigh frequency) radio waves and extending into the INFRARED RAYS frequencies. EHF Waves,Extremely High Frequency Radio Waves,Micro Wave,Micro Waves,Ultrahigh Frequency Waves,Microwave Radiation,EHF Wave,Micro Waves,Microwave,Microwave Radiations,Radiation, Microwave,Ultrahigh Frequency Wave,Wave, EHF,Wave, Micro,Wave, Ultrahigh Frequency,Waves, Micro
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000178 Acrylamides Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
April 2011, Bioorganic & medicinal chemistry letters,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
March 2020, Molecules (Basel, Switzerland),
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
August 2012, European journal of medicinal chemistry,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
December 2014, Molecules (Basel, Switzerland),
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
May 2024, Bioorganic & medicinal chemistry letters,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
December 2019, Steroids,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
July 2022, Archiv der Pharmazie,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
January 2024, Chemical biology & drug design,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
November 1952, Nature,
Ranjeet Bairwa, and Manoj Kakwani, and Nilesh R Tawari, and Jaya Lalchandani, and M K Ray, and M G R Rajan, and Mariam S Degani
October 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!